In phase III SURE 1 trial sulopenem meets endpoint for uncomplicated urinary tract infections.- Iterum Therapeutics
Iterum Therapeutics announced topline results from its phase III SURE 1 clinical trial of sulopenem for the treatment of Uncomplicated Urinary Tract Infections (uUTI). Sulopenem is a novel… read more.